Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep;9(9):1909-14.
doi: 10.3748/wjg.v9.i9.1909.

Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901

Bing-Qing Chen  1 , Yan-Mei Yang, Yan-Hui Gao, Jia-Ren Liu, Ying-Ben Xue, Xuan-Lin Wang, Yu-Mei Zheng, Jing-Shu Zhang, Rui-Hai Liu
Affiliations

Inhibitory effects of c9, t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901

Bing-Qing Chen et al. World J Gastroenterol. 2003 Sep.

Abstract

Aim: To investigate the effect of c9, t11-conjugated linoleic acid (c9, t11-CLA) on the invasion of human gastric carcinoma cell line and its possible mechanism of preventing metastasis.

Methods: Using reconstituted basement membrane invasion, chemotaxis, adhesion, PAGE substrate zymography and RT-PCR assays, we analyzed the abilities of invasion, direct migration, adhesion of intracellular matrix, as well as the activity of type IV collagenase and expression of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 mRNA in SGC-7901 cells which were treated with gradually increased concentrations (25, 50, 100 and 200 micromol/L) of c9, t11-CLA for 24 h.

Results: At the concentrations of 200 micromol/L, 100 micromol/L and 50 micromol/L, c9,t11-CLA suppressed the invasion of SGC-7901 cells into the reconstituted basement membrane by 53.7 %, 40.9 % and 29.3 %, respectively, in comparison with the negative control. Only in the 200 micromol/L c9,t11-CLA group, the chemotaxis of SGC-7901 cells was inhibited by 16.0 % in comparison with the negative control. C9,t11-CLA also could inhibit the adhesion of SGC-7901 cells to laminin, fibronectin and Matrigel, increase the expression of TIMP-1 and TIMP-2 mRNA, and reduce type IV collagenase activities in the serum-free medium supernatant of SGC-7901 cells.

Conclusion: c9,t11-CLA can inhibit the invasion of SGC-7901 cells at multiple procedures in tumor metastasis cascade, which may be associated with the induction of TIMP-1 and TIMP-2 mRNA expression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of c9,t11-CLA on invasion of SGC-7901 cells detected by reconstituted basement membrane invasion assay (100 ×). A: There are more invading SGC-7901 cells in the nega-tive control group. B: There are less invading SGC-7901 cells in the 200 μmol/L c9,t11-CLA group.
Figure 2
Figure 2
Effect of c9,t11-CLA on chemotaxic migration of SGC-7901 cells detected by chemotaxied-motion assay (100 ×). A: There are more invading SGC-7901 cells in the negative con-trol group. B: There are less invading SGC-7901 cells in the 200 μmol/L c9,t11-CLA group.
Figure 3
Figure 3
Effect of c9,t11-CLA on the attachment ability of SGC-7901 cells.
Figure 4
Figure 4
Effects of c9,t11-CLA on Gelatinase secretion in SGC-7901 cells detected by zymography. A, B, C, D are 200 μmol/L, 100 μmol/L, 50 μmol/L, 25 μmol/L c9,t11-CLA, respectively. E is the negative control group.
Figure 5
Figure 5
Quantitation of 92 and 72 kDa type IV Collagenase levels in SGC-7901 cells by ChemiImager 4000. A, B, C, D are 200 μmol/L, 100 μmol/L, 50 μmol/L, 25 μmol/L c9,t11-CLA, respectively. E is the negative control group.
Figure 6
Figure 6
Effects of c9,t11-CLA on expression of TIMP-1 mRNA and TIMP-2 mRNA in SGC-7901 cells detected by RT-PCR. Top: Expression of TIMP-1 mRNA. Middle: Expression of TIMP-2 mRNA. A, B, C, D are 20 μmol/L, 100 μmol/L, 50 μmol/L, 25 μmol/L c9,t11-CLA, respectively. E is the negative control group.
Figure 7
Figure 7
Quantitation of TIMP-1 and TIMP-2 mRNA levels in the SGC-7901 cells by ChemiImager 4000. A, B, C, D are 200 μmol/L, 100 μmol/L, 50 μmol/L, 25 μmol/L c9,t11-CLA, respectively. E is the negative control group.
See this image and copyright information in PMC

References

    1. Sébédio JL, Gnaedig S, Chardigny JM. Recent advances in conjugated linoleic acid research. Curr Opin Clin Nutr Metab Care. 1999;2:499–506. - PubMed
    1. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000;223:8–13. - PubMed
    1. Pariza MW, Park Y, Cook ME. Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999;52:107–110. - PubMed
    1. Whigham LD, Cook ME, Atkinson RL. Conjugated linoleic acid: implications for human health. Pharmacol Res. 2000;42:503–510. - PubMed
    1. MacDonald HB. Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr. 2000;19:111S–118S. - PubMed

Publication types

MeSH terms

Substances